Ibaraki, Japan

Mikio Takeda

This inventor holds 2 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 1988-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikio Takeda. Retrieved from https://idiyas.com/inventor/mikio-takeda-my3m9vmt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mikio Takeda: Innovator in Pharmaceutical Chemistry

Introduction

Mikio Takeda is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic compounds. His work focuses on innovative solutions for heart diseases and related health issues.

Latest Patents

Mikio Takeda holds 2 patents related to 1,4-benzodioxane derivatives. These derivatives are represented by a specific general formula, wherein p stands for an integer of 0-2, and X and Y can represent various chemical groups. The patents describe their preparation processes and their applications as therapeutic and preventive compositions for ischemic heart diseases and heart failure. Additionally, they detail their use in controlling blood pressure during surgical operations.

Career Highlights

Mikio Takeda is associated with Eisai Company, Limited, where he has been instrumental in advancing pharmaceutical research. His innovative work has contributed to the development of new therapeutic options for patients suffering from cardiovascular conditions.

Collaborations

Throughout his career, Mikio has collaborated with notable colleagues, including Toshinobu Kunii and Norio Minami. These collaborations have further enhanced the impact of his research in the pharmaceutical industry.

Conclusion

Mikio Takeda's contributions to pharmaceutical chemistry, particularly through his patents on 1,4-benzodioxane derivatives, highlight his role as an innovator in the field. His work continues to influence therapeutic approaches for heart diseases and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…